You are here: Industry Insights > COVID-19

News List

Umifenovir gets DCGI nod for Phase III clinical trial against COVID-19 expresspharma
June 19, 2020
CSIR-CDRI has developed the process technology for Umifenovir and licensed the process technology for manufacturing and marketing of the drug to Medizest Pharmaceuticals, Goa, which has already received test license from DCGI.
The medical face mask market is expected to grow at a CAGR of over 26% during the period 2019-2025 prnewswire
June 18, 2020
The medical face mask market is expected to grow at a CAGR of over 26% during the period 2019–2025.
Researchers Overdosing COVID-19 Patients on Hydroxychloroquine, States Association of American Physicians & Surgeons (AAPS) prnewswire
June 18, 2020
Until President Trump suggested that hydroxychloroquine (HCQ, Plaquenil?) might help COVID-19 patients, it was generally considered a very safe drug, observes the Association of American Physicians & Surgeons (AAPS).
Evgen's SFX-01 selected for COVID-19 trial pharmatimes
June 18, 2020
Evgen Pharma's lead candidate SFX-01 has been selected for evaluation in a randomised Phase II/III trial, to be sponsored by the University of Dundee, which aims to investigate its potential as a treatment for COVID-19.
Nanosponges could intercept coronavirus infection worldpharmanews
June 18, 2020
Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.
MHRA suspends patient recruitment to UK COVID-19 hydroxychloroquine trials europeanpharmaceuticalreview
June 18, 2020
After evidence suggesting hydroxychloroquine has no benefit against COVID-19, the MHRA has suspended further recruitment to clinical trials investigating the drug in the UK.
UK approves dexamethasone for Covid-19 patients after positive data pharmaceutical-technology
June 18, 2020
The UK Government has authorised the use of anti-inflammatory drug dexamethasone for the treatment of Covid-19 on the National Health Service (NHS), immediately after the report of positive data from the RECOVERY trial.
PTC Begins Phase II/III Trial of PTC299 in COVID-19 contractpharma
June 18, 2020
PTC299 has a novel dual-mechanism of action that has the potential to address high viral replication and uncontrolled inflammatory response.
COVID-19 disruption of clinical trials starting to slow: GlobalData expresspharma
June 18, 2020
FDA issued guidance recommends methods that could help keep the research going which includes virtual visits, phone interviews, self-administration, and remote monitoring.
WHO moves to update COVID-19 guidance after ‘great news’ in dexamethasone study expresspharma
June 18, 2020
Trial results announced showed dexamethasone, used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill COVID-19 patients admitted to hospital.